Associations of type 2 diabetes mellitus with cancer and autoimmune diseases. A population-based epidemiological study in Sweden.
(2015) In Lund University Faculty of Medicine Doctoral Dissertation Series 2015:55.- Abstract
- This thesis aimed to search for epidemiological evidence supporting the associations of type 2 diabetes mellitus (T2DM) with cancer and autoimmune diseases (ADs) by analysing several Swedish national registries. T2DM shares risk factors with cancer, such as obesity, diet, stress, and physical inactivity. However, it is unclear whether the associations with several types of cancers are due to shared risk factors, shared genes or metabolic disturbances of the underlying disease. Immunological data show that T2DM has autoimmune features, including the presence of autoantibodies against pancreatic β-cells and self-reactive T-cells. This doctoral project consists of four epidemiological cohort studies conducted using several population-based... (More)
- This thesis aimed to search for epidemiological evidence supporting the associations of type 2 diabetes mellitus (T2DM) with cancer and autoimmune diseases (ADs) by analysing several Swedish national registries. T2DM shares risk factors with cancer, such as obesity, diet, stress, and physical inactivity. However, it is unclear whether the associations with several types of cancers are due to shared risk factors, shared genes or metabolic disturbances of the underlying disease. Immunological data show that T2DM has autoimmune features, including the presence of autoantibodies against pancreatic β-cells and self-reactive T-cells. This doctoral project consists of four epidemiological cohort studies conducted using several population-based nationwide Swedish databases, which collectively contain information on socioeconomic status, comorbidities and demographics. We found that the risks of 24 cancers were increased in patients with T2DM, and that the highest risks were for liver cancer and pancreatic cancer. The cancer risks in siblings and spouses of individuals with T2DM were not increased. In addition, cancer patients with a previous T2DM diagnosis had a worse prognosis than those without T2DM, and the observed high cause-specific mortality in cancer patients with T2DM may be independent of age at cancer diagnosis and tumour stage. Prior diagnosis of T2DM in cancer patients was associated with an increased risk of dying from myocardial infarction, “other bacterial disease”, urinary system disease, hypertensive disease, and arterial disease. T2DM risk was increased after diagnosis of any one of 27 ADs, and the highest standardized incidence ratios (SIRs) were for chorea minor, lupoid hepatitis, and Addison’s disease. In conclusion, this project showed that pre-existing T2DM increased the subsequent risk of a range of site-/type-specific cancers, an effect that is potentially mediated by metabolic changes. Also, the mortality was increased in cancer patients with T2DM. In addition, the risk of T2DM was increased after many ADs suggesting that chronic inflammation-driven autoimmune activation may be a shared initiation mechanism for T2D and many ADs. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5336359
- author
- Liu, Xiangdong LU
- supervisor
-
- Jianguang Ji LU
- Kristina Sundquist LU
- Xinjun Li LU
- Kari Hemminki LU
- opponent
-
- Associate Professor Jonasson, Junmei, University of Gothenburg
- organization
- publishing date
- 2015
- type
- Thesis
- publication status
- published
- subject
- keywords
- Type 2 diabetes mellitus, cancer, autoimmune disease, cause of death, hazard ratio, standardized incidence ratio, survival, risk factor
- in
- Lund University Faculty of Medicine Doctoral Dissertation Series
- volume
- 2015:55
- pages
- 132 pages
- publisher
- Department of Clinical Sciences, Lund University
- defense location
- CRC Aula, Clinical Research Centre, Jan Waldenströms gata 35, Malmö
- defense date
- 2015-05-21 09:00:00
- ISSN
- 1652-8220
- ISBN
- 978-91-7619-134-7
- language
- English
- LU publication?
- yes
- id
- 9d89ce8c-44a8-4318-ab66-7197fea35c7d (old id 5336359)
- date added to LUP
- 2016-04-01 15:03:58
- date last changed
- 2019-05-22 01:30:10
@phdthesis{9d89ce8c-44a8-4318-ab66-7197fea35c7d,
abstract = {{This thesis aimed to search for epidemiological evidence supporting the associations of type 2 diabetes mellitus (T2DM) with cancer and autoimmune diseases (ADs) by analysing several Swedish national registries. T2DM shares risk factors with cancer, such as obesity, diet, stress, and physical inactivity. However, it is unclear whether the associations with several types of cancers are due to shared risk factors, shared genes or metabolic disturbances of the underlying disease. Immunological data show that T2DM has autoimmune features, including the presence of autoantibodies against pancreatic β-cells and self-reactive T-cells. This doctoral project consists of four epidemiological cohort studies conducted using several population-based nationwide Swedish databases, which collectively contain information on socioeconomic status, comorbidities and demographics. We found that the risks of 24 cancers were increased in patients with T2DM, and that the highest risks were for liver cancer and pancreatic cancer. The cancer risks in siblings and spouses of individuals with T2DM were not increased. In addition, cancer patients with a previous T2DM diagnosis had a worse prognosis than those without T2DM, and the observed high cause-specific mortality in cancer patients with T2DM may be independent of age at cancer diagnosis and tumour stage. Prior diagnosis of T2DM in cancer patients was associated with an increased risk of dying from myocardial infarction, “other bacterial disease”, urinary system disease, hypertensive disease, and arterial disease. T2DM risk was increased after diagnosis of any one of 27 ADs, and the highest standardized incidence ratios (SIRs) were for chorea minor, lupoid hepatitis, and Addison’s disease. In conclusion, this project showed that pre-existing T2DM increased the subsequent risk of a range of site-/type-specific cancers, an effect that is potentially mediated by metabolic changes. Also, the mortality was increased in cancer patients with T2DM. In addition, the risk of T2DM was increased after many ADs suggesting that chronic inflammation-driven autoimmune activation may be a shared initiation mechanism for T2D and many ADs.}},
author = {{Liu, Xiangdong}},
isbn = {{978-91-7619-134-7}},
issn = {{1652-8220}},
keywords = {{Type 2 diabetes mellitus; cancer; autoimmune disease; cause of death; hazard ratio; standardized incidence ratio; survival; risk factor}},
language = {{eng}},
publisher = {{Department of Clinical Sciences, Lund University}},
school = {{Lund University}},
series = {{Lund University Faculty of Medicine Doctoral Dissertation Series}},
title = {{Associations of type 2 diabetes mellitus with cancer and autoimmune diseases. A population-based epidemiological study in Sweden.}},
volume = {{2015:55}},
year = {{2015}},
}